48 related articles for article (PubMed ID: 21947124)
1. Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects.
Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174046
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer.
Narvaez C; Schild SE; Rades D
In Vivo; 2021; 35(1):411-415. PubMed ID: 33402490
[TBL] [Abstract][Full Text] [Related]
3. [Reasons for the terms "radiosurgery" and "Gamma Knife"].
Hamm K; Surber G
HNO; 2017 Sep; 65(9):775-776. PubMed ID: 28776076
[No Abstract] [Full Text] [Related]
4. [2014: activation of OPS 8-980 "Complex intensive care treatment" by DIMDI].
Engelmann L
Med Klin Intensivmed Notfmed; 2014 Feb; 109(1):61. PubMed ID: 24352621
[No Abstract] [Full Text] [Related]
5. Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.
Budach V; Becker ET; Boehmer D; Badakhshi H; Jahn U; Wernecke KD; Stromberger C
Strahlenther Onkol; 2014 Mar; 190(3):250-5. PubMed ID: 24322993
[TBL] [Abstract][Full Text] [Related]
6. High-dose radiotherapy alone for patients with T4-stage laryngeal cancer.
Mucha-Małecka A; Składowski K
Strahlenther Onkol; 2013 Aug; 189(8):632-8. PubMed ID: 23824108
[TBL] [Abstract][Full Text] [Related]
7. Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer.
Brömme JO; Schmücking M; Arnold A; Giger R; Rauch D; Leiser D; Plasswilm L; Geretschläger A; Ghadjar P; Aebersold DM
Strahlenther Onkol; 2013 Aug; 189(8):618-24. PubMed ID: 23821138
[TBL] [Abstract][Full Text] [Related]
8. Acute mucosal reactions in patients with head and neck cancer. Three patterns of mucositis observed during radiotherapy.
Wygoda A; Rutkowski T; Hutnik M; Składowski K; Goleń M; Pilecki B
Strahlenther Onkol; 2013 Jul; 189(7):547-51. PubMed ID: 23700206
[TBL] [Abstract][Full Text] [Related]
9. 125I seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescents.
Zheng L; Zhang J; Song T; Zhang J; Yu G; Zhang Y
Strahlenther Onkol; 2013 May; 189(5):401-6. PubMed ID: 23519359
[TBL] [Abstract][Full Text] [Related]
10. Acute mucosal radiation reactions in patients with head and neck cancer. Patterns of mucosal healing on the basis of daily examinations.
Wygoda A; Składowski K; Rutkowski T; Hutnik M; Goleń M; Pilecki B; Przeorek W; Lukaszczyk-Wideł B
Strahlenther Onkol; 2012 Aug; 188(8):686-91. PubMed ID: 22729281
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in radiation oncology. "Myocardial metastasis" in PET-CT after palliative radiation treatment of the left 5th rib.
Kröpil P; Budach W; Bölke E; Gerber PA; Zinnmann F; Hautzel H; Antoch G; Scherer A; Matuschek C
Strahlenther Onkol; 2012 Apr; 188(4):359-62. PubMed ID: 22349711
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
13. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
15. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
17. Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks) : an alternative in the treatment of locally advanced head and neck cancer.
Kubes J; Cvek J; Vondracek V; Pala M; Feltl D
Strahlenther Onkol; 2011 Oct; 187(10):651-5. PubMed ID: 21947124
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
